课题基金 / 基金详情

颅脑创伤后神经干细胞RBM3通过可变剪接增强外泌体circWdr33修复神经元受损突触的机制研究

批准号:
82101447
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
赵程程
依托单位:
学科分类:
神经损伤、修复与再生
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
赵程程

项目摘要

结项摘要

相似基金

相关文献

中文摘要
神经干细胞参与颅脑创伤(TBI)后受损神经元突触的修复,但机制不明。我们前期发现:冷休克蛋白RBM3通过与Wdr33前体mRNA结合,影响其可变剪接上调神经干细胞外泌体内环状RNA-circWdr33表达。富含circWdr33的神经干细胞外泌体可促进TBI小鼠受损神经元突触的修复。进一步实验表明:circWdr33可结合Nova2蛋白,减少其与E3泛素酶RNF180结合,抑制Nova2泛素化降解,进而促进受损突触修复。故我们推测:TBI后RBM3通过可变剪接上调神经干细胞外泌体内circWdr33表达,后者传递至损伤神经元中结合Nova2蛋白,抑制RNF180介导的Nova2泛素化降解,促进神经元受损突触修复。我们拟采用神经元牵张损伤模型、小鼠脑皮质损伤模型,病毒载体等方法,阐明RBM3通过外泌体途径介导神经干细胞修复神经元受损突触的机制,为TBI后神经功能修复治疗提供新方向及作用靶点。
英文摘要
Neural stem cells (NSCs) play a critical role in the repair of damaged synapses after traumatic brain injury (TBI). However, the mechanism is still unknown. Our previous study found that the cold shock protein RBM3 combined with pre-mRNA of Wdr33 to increase the expression of exosomal circular RNA-circWdr33 derived from NSCs through alternative splicing. Moreover, circWdr33 enriched exosomes derived from NSCs could promote the repair of damaged synapses in the pericontusion region after TBI in mice. Further experiments showed that circWdr33 could bind to Nova2 to inhibit RNF180 mediated ubiquitination degradation of Nova2, which can promote the repair of damaged synapses. Therefore, we propose a hypothesis: RBM3 increases the expression of circWdr33 in exosomes derived from NSCs through alternative splicing after TBI. These circWdr33 enriched exosomes can transmit to injured neurons and bind to Nova2 to inhibit RNF180 mediated ubiquitination degradation of Nova2, which can promote the repair of damaged synapses. We intend to clarify the role of RBM3 regulated exosomes derived from NSCs in the repair of damaged synapses by using stretch injury model of neurons, controlled cortical impact model of mice and virus vector. Our study may provide a new therapeutic target for rehabilitation of neurological function after TBI.
背景:颅脑创伤(TBI)后,损伤神经干细胞源外泌体促进损伤神经元再生,但机制不明确。本研究揭示神经干细胞RBM3通过circWdr33调控其外泌体源miR-20b-5p促进损伤神经元再生机制。.方法:使用慢病毒构建RBM3过表达神经干细胞,通过经典梯度离心法收集其外泌体,鉴定后将外泌体经尾静脉注射TBI小鼠,7天后golgi染色检测损伤周围区神经元神经突起总长度及突触数量;爬杆实验检测小鼠运动功能改变。二代测序检测神经干细胞源外泌体microRNA表达谱变化。将miR-20b-5p经尾静脉注射TBI小鼠,3天及7天后TUNEL染色检测神经元凋亡比例;WB实验检测凋亡蛋白表达水平变化;golgi染色检测损伤周围区神经元神经突起总长度及突触数量;爬杆实验检测小鼠运动功能改变。双荧光素酶报告实验检测miR-20b-5p是否结合PTEN。神经元与MK-2206共培养检测miR-20b-5p通过PI3K-AKT通路调控神经元再生。RNA pulldown实验结合RT-qPCR验证RBM3通过可变剪接促进circWdr33生成。CircRIP结合RT-qPCR验证circWdr33结合pri-miR-20b,促进其成熟。.结果:过表达RBM3神经干细胞源外泌体促进TBI小鼠损伤神经突起及突触再生并改善其运动功能。二代测序发现过表达RBM3神经干细胞源外泌体内miR-20b-5p含量升高。其机制为RBM3通过可变剪接促进神经干细胞circWdr33生成,后者可与miRNA前体pri-miR-20b结合,促进miR-20b-5p成熟,使神经干细胞外泌体内miR-20b-5p含量升高。miR-20b-5p可抑制TBI小鼠损伤神经元凋亡,促进损伤神经突起及突触再生,并改善TBI小鼠运动功能。miR-20b-5p通过抑制PTEN表达,经PI3K-AKT通路促进损伤神经突起及突触再生。.结论:RBM3通过结合Wdr33 pre-mRNA促进circWdr33表达,后者结合miRNA前体pri-miR-20b,上调神经干细胞源外泌体内miR-20b-5p含量。神经干细胞源外泌体miR-20b-5p通过抑制神经元PTEN蛋白表达,经PI3K-AKT通路促进损伤神经突起及突触再生,改善TBI小鼠运动功能。本研究为TBI后神经修复治疗提供新靶点及研究方向,故具有重要研究意义及临床价值。
国内基金
海外基金